Gulf Pharmaceutical Industries (Julphar) announced the sale of 51% of its ownership in Alpha Pharma.
The company expected, in a disclosure, yesterday, that it sent to the Abu Dhabi Securities Exchange, that the sale process will result in a reduction of 10% to 12% of the total assets of the consolidated group, as on March 31, 2021. The company said: The financial impact of the deal will appear during the quarter. The second of this year, and indicated that there was no material impact on the company’s operations as a result of the deal, which is expected to be completed in the third quarter of 2021.
Follow the economic statement via Google News